Resistant Hypertension, Elevated Aldosterone/Renin Ratio and Reduced RGS2: A Pathogenetic Link Deserving Further Investigations?

QR Code

Resistant Hypertension, Elevated Aldosterone/Renin Ratio and Reduced RGS2: A Pathogenetic Link Deserving Further Investigations?

None

Saved in:

Bibliographic Details
Main Authors:	Semplicini, Andrea, Stella, Federica, Ceolotto, Giulio
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/31009
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Renin-Angiotensin-Aldosterone System in Dialysis Patients
by: Morishita, Yoshiyuki, et al.
Published: (2012)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

Glaciology in the Russian Geographical Society: 170-jubilee of RGS
by: Yu. P. Suprunenko
Published: (2015-07-01)

How to negotiate the raise you deserve /
by: Satterfield, Mark E.
Published: (1993)

Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity
by: Xuyu Gu, et al.
Published: (2025-05-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM GENES POLYMORPHISM AND RELATION WITH VASOPRESSORS IN ESSENTIAL HYPERTENSION AMONG DAGESTAN INHABITANTS
by: M. Z. Saidov, et al.
Published: (2017-05-01)

Role of renin-angiotensin-aldosterone system gene polymorphisms in the development of diastolic dysfunction in female patients with hypertension
by: Mariya A. Grenaderova, et al.
Published: (2025-01-01)

Correction: Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity
by: Xuyu Gu, et al.
Published: (2025-06-01)

On the physicians who deserved «practical official distinctions»
by: V. P. Nikolaev
Published: (2005-12-01)

Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2020-04-01)

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic
by: E. V. Sayutina, et al.
Published: (2022-03-01)

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
by: L. M. Resnick, et al.
Published: (2011-12-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2009-06-01)

THE AGES DIFFERENCES IN BLOOD PRESSURE DYNAMICS, RENIN-ALDOSTERON SYSTEM STATE AND LIPID PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION AND THYREOTOXYCOSIS
by: P. H. Dzhanashiya, et al.
Published: (2003-12-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

Post hoc comparison of the intrarenal and circulating renin‐angiotensin(‐aldosterone) systems in cats with ischemia‐induced chronic kidney disease
by: Jane H. C. Huang, et al.
Published: (2025-06-01)

Global Diseases Deserve Global Solutions: Alzheimer’s Disease
by: Emma Twiss, et al.
Published: (2025-06-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

RENIN AND ALDOSTERONE PRODUCTION IN CHILDREN WITH HYDRONEPHROSIS WITH RELATION TO THE SEVERITY OF NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AND TIME OF URINAL OBSTRUCTION ELIMINATION
by: A.M. Mambetova, et al.
Published: (2011-11-01)

ANALYSIS OF POLYMORPHISMS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND RELATION TO VASOPRESSORS IN ESSENTIAL SYSTEMIC HYPERTENSION WITH THE LEFT VENTRICLE HYPERTROPHY IN DAGESTAN REPUBLIC
by: M. Z. Saidov, et al.
Published: (2017-11-01)

Influence of blockers of the renin-angiotensin-aldosterone system on the functional state of the right ventricle myocardial infarction left ventricular anterior wall
by: G. V. Tolparov
Published: (2016-06-01)

Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community
by: Roberto Pecoits‐Filho, et al.
Published: (2025-08-01)

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
by: Roberto Pecoits-Filho, et al.
Published: (2025-09-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

Comparative effects of renin-angiotensin-aldosterone system modulators on right heart function and prognosis in patients with severe systolic chronic heart failure
by: K. G. Adamyan, et al.
Published: (2012-12-01)

THE INFLUENCE OF INDAPAMIDE ON BLOOD PRESSURE DAILY PROFILE, HEMODYNAMICS AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS OLDER THAN 55 YEARS
by: S. V. Shlyk, et al.
Published: (2002-02-01)

INVERSION OF THE CONCEPT ABOUT BIOLOGICAL ROLE OF RENIN → ANGIOTENSIN-II → ALDOSTERONE SYSTEM AND FUNCTION OF ARTERIAL BLOOD PRESSURE AS A METABOLISM REGULATOR
by: V. N. Titov
Published: (2015-09-01)

Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features
by: Salvatore Corallo, et al.
Published: (2025-08-01)

The Pathogenetic Link Between Stress and Rheumatic Diseases
by: Malysheva, O., et al.
Published: (2012)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)